Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
39268016 | 0 | Ladak R, Sementilli M, Calandra J, et al. Physician practice patterns on the use of inferior vena cava filters in venous thromboembolism. Res Pract Thromb Haemost. 2024 Aug 5;8(6):102540. doi: 10.1016/j.rpth.2024.102540. eCollection 2024 Aug. | |
38375212 | 0 | Almanaseer A, Chin-Yee B, Ho J, et al. An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis. Adv Hematol. 2024 Feb 12;2024:3056216. doi: 10.1155/2024/3056216. eCollection 2024. | |
37519483 | 0 | MacNeill M, Mansory EM, Lazo-Langner A, et al. Acquired Hemophilia A Masquerading as Bleeding on Anticoagulation: A Case Report Including Key Laboratory Considerations. Cureus. 2023 Jun 27;15(6):e41029. doi: 10.7759/cureus.41029. eCollection 2023 Jun. | |
37340812 | 0 | Wang TF, Grubic N, Carrier M, et al. Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty. Am J Hematol. 2023 Jun 21. doi: 10.1002/ajh.26994. | |
37150028 | 0 | Chiu J, Lazo-Langner A. Venous thromboembolism in hematopoietic stem cell transplantation: A narrative review. Thromb Res. 2023 Apr 26;226:141-149. doi: 10.1016/j.thromres.2023.04.019. | |
36710196 | 0 | Caiano L, Kovacs MJ, Lazo-Langner A, et al. The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism. J Thromb Haemost. 2022 Dec 30:S1538-7836(22)19071-9. doi: 10.1016/j.jtha.2022.12.021. | |
36299810 | 0 | Mansory EM, Abu-Farhaneh M, Iansavitchene A, et al. Venous and Arterial Thrombosis in Ambulatory and Discharged COVID-19 Patients: A Systematic Review and Meta-analysis. TH Open. 2022 Sep 19;6(3):e276-e282. doi: 10.1055/a-1913-4377. eCollection 2022 Jul. | |
36076354 | 0 | Porres-Aguilar M, Mukherjee D, Didia SC, et al. Which are the optimal thromboprophylaxis strategies for hospitalized patients with COVID-19? current controversies. Vascular. 2022 Sep 8:17085381221126235. doi: 10.1177/17085381221126235. | |
35809961 | 0 | Porres-Aguilar M, Mukherjee D, Lazo-Langner A. Thromboprophylaxis Strategies for Hospitalized Patients With COVID-19. Chest. 2022 Jul;162(1):e69-e70. doi: 10.1016/j.chest.2022.03.038. | |
35679460 | 0 | Wells PS, Tritschler T, Khan F, et al. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism. Blood Adv. 2022 Jun 9. pii: 485510. doi: 10.1182/bloodadvances.2022007027. | |
35439303 | 0 | Ageno W, Beyer-Westendorf J, Contino L, et al. Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study. Blood Adv. 2022 Apr 19. pii: 484971. doi: 10.1182/bloodadvances.2022007397. | |
35290837 | 0 | Abufarhaneh M, Pandya RK, Alkhaja A, et al. Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis. Thromb Res. 2022 Mar 4;213:47-56. doi: 10.1016/j.thromres.2022.02.022. | |
34240001 | 0 | Mansory EM, Srigunapalan S, Lazo-Langner A. Venous Thromboembolism in Hospitalized Critical and Noncritical COVID-19 Patients: A Systematic Review and Meta-analysis. TH Open. 2021 Jul 6;5(3):e286-e294. doi: 10.1055/s-0041-1730967. eCollection 2021 Jul. | |
34108229 | 0 | Kovacs MJ, Wells PS, Anderson DR, et al. Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial. BMJ. 2021 Jun 9;373:n1205. doi: 10.1136/bmj.n1205. | |
33949182 | 0 | Raslan OM, Lazo-Langner A. Treatment of retinal vein thrombosis: what about anticoagulants? Minerva Med. 2021 May 5. pii: S0026-4806.21.07474-7. doi: 10.23736/S0026-4806.21.07474-7. | |
33940219 | 0 | Porres-Aguilar M, Lazo-Langner A, Panduro A, et al. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis. Ann Hepatol. 2021 Jul-Aug;23:100356. doi: 10.1016/j.aohep.2021.100356. Epub 2021 Apr 30. | |
33798804 | 0 | Kawata E, Siew DA, Payne JG, et al. Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes. Thromb Res. 2021 Jun;202:90-95. doi: 10.1016/j.thromres.2021.03.018. Epub 2021 Mar 21. | |
33317427 | 0 | Endres K, St Bernard R, Chin-Yee I, et al. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation. Hematology. 2020 Dec;25(1):489-493. doi: 10.1080/16078454.2020.1855745. | |
33160117 | 0 | Payne JG, Tagalakis V, Wu C, et al. Current estimates of the incidence of acute venous thromboembolic disease in Canada: A meta-analysis. Thromb Res. 2021 Jan;197:8-12. doi: 10.1016/j.thromres.2020.10.030. Epub 2020 Nov 1. | |
32799129 | 0 | Kovacs MR, Lazo-Langner A, Louzada ML, et al. Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism. Thromb Res. 2020 Nov;195:231-232. doi: 10.1016/j.thromres.2020.07.052. Epub 2020 Jul 30. | |
32788103 | 0 | Kovacs MR, Lazo-Langner A, Kovacs MJ. Long term monitoring of patients with positive lupus anticoagulant and antiphospholipid antibodies. Are all cases persistently positive? Thromb Res. 2020 Oct;194:119-120. doi: 10.1016/j.thromres.2020.06.031. Epub 2020 Jun 19. | |
32676543 | 0 | Wang YP, Kehar R, Iansavitchene A, et al. Bleeding Risk in Nonvalvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants and Warfarin: A Systematic Review and Meta-Analysis of Observational Studies. TH Open. 2020 Jul 13;4(3):e145-e152. doi: 10.1055/s-0040-1714918. eCollection 2020 Jul. | |
32485418 | 0 | Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res. 2020 Aug;192:152-160. doi: 10.1016/j.thromres.2020.05.039. Epub 2020 May 27. | |
31893562 | 0 | Al-Ani F, Wang YP, Lazo-Langner A. Development of a Clinical Prediction Rule for Venous Thromboembolism in Patients with Acute Leukemia. Thromb Haemost. 2020 Feb;120(2):322-328. doi: 10.1055/s-0039-3400303. Epub 2020 Jan 1. | |
31774957 | 0 | Kearon C, de Wit K, Parpia S, et al. Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability. N Engl J Med. 2019 Nov 28;381(22):2125-2134. doi: 10.1056/NEJMoa1909159. | |
31294317 | 0 | Lazo-Langner A. Studies in upper extremity deep vein thrombosis: Addressing the knowledge gaps. Res Pract Thromb Haemost. 2019 May 15;3(3):312-314. doi: 10.1002/rth2.12210. eCollection 2019 Jul. | |
30921533 | 0 | Ahrari A, Al-Ani F, Wang YP, et al. Treatment of venous thromboembolism in acute leukemia: A systematic review. Thromb Res. 2019 Jun;178:1-6. doi: 10.1016/j.thromres.2019.03.014. Epub 2019 Mar 20. | |
30553163 | 0 | Thiyagarajah K, Ellingwood L, Endres K, et al. Post-thrombotic syndrome and recurrent thromboembolism in patients with upper extremity deep vein thrombosis: A systematic review and meta-analysis. Thromb Res. 2019 Feb;174:34-39. doi: 10.1016/j.thromres.2018.12.012. Epub 2018 Dec 8. | |
30511879 | 0 | Carrier M, Abou-Nassar K, Mallick R, et al. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4. | |
30046751 | 0 | Lazo-Langner A, Liu K, Shariff S, et al. Immigration, region of origin, and the epidemiology of venous thromboembolism: A population-based study. Res Pract Thromb Haemost. 2018 May 27;2(3):469-480. doi: 10.1002/rth2.12113. eCollection 2018 Jul. | |
29772489 | 0 | Lazo-Langner A, Al-Ani F, Weisz S, et al. Prevention of venous thromboembolism in pregnant patients with a history of venous thromboembolic disease: A retrospective cohort study. Thromb Res. 2018 Jul;167:20-25. doi: 10.1016/j.thromres.2018.05.005. Epub 2018 May 5. | |
29564837 | 0 | Schulman S, Gross PL, Ritchie B, et al. Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study. Thromb Haemost. 2018 May;118(5):842-851. doi: 10.1055/s-0038-1636541. Epub 2018 Mar 21. | |
28823585 | 0 | Massicotte-Azarniouch D, Bader Eddeen A, Lazo-Langner A, et al. Risk of Venous Thromboembolism in Patients by Albuminuria and Estimated GFR. Am J Kidney Dis. 2017 Dec;70(6):826-833. doi: 10.1053/j.ajkd.2017.07.003. Epub 2017 Aug 18. | |
28160670 | 0 | Coyle K, Carrier M, Lazo-Langner A, et al. Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism. Thromb Res. 2017 Mar;151:67-71. doi: 10.1016/j.thromres.2017.01.007. Epub 2017 Jan 25. | |
27931012 | 0 | Garcia-Horton A, Kovacs MJ, Abdulrehman J, et al. Impact of thrombophilia screening on venous thromboembolism management practices. Thromb Res. 2017 Jan;149:76-80. doi: 10.1016/j.thromres.2016.11.023. Epub 2016 Dec 1. | |
27838473 | 0 | Garcia-Horton A, Al-Ani F, Lazo-Langner A. Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management. Thromb Res. 2016 Dec;148:118-124. doi: 10.1016/j.thromres.2016.11.004. Epub 2016 Nov 5. | |
27346552 | 0 | Boonyawat K, Wang L, Lazo-Langner A, et al. The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trial. Thromb Haemost. 2016 Aug 30;116(3):480-5. doi: 10.1160/TH16-04-0320. Epub 2016 Jun 23. | |
27318246 | 0 | Ma K, Wells P, Guzman C, et al. A multicenter prospective study of risk factors and treatment of unusual site thrombosis. Thromb Res. 2016 Aug;144:100-5. doi: 10.1016/j.thromres.2016.04.014. Epub 2016 Apr 26. | |
26817957 | 0 | Ihaddadene R, Corsi DJ, Lazo-Langner A, et al. Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism. Blood. 2016 Apr 21;127(16):2035-7. doi: 10.1182/blood-2015-11-682963. Epub 2016 Jan 27. | |
26780742 | 0 | Ageno W, Beyer-Westendorf J, Garcia DA, et al. Guidance for the management of venous thrombosis in unusual sites. J Thromb Thrombolysis. 2016 Jan;41(1):129-43. doi: 10.1007/s11239-015-1308-1. | |
26553020 | 0 | Al-Ani F, Shariff S, Siqueira L, et al. Identifying venous thromboembolism and major bleeding in emergency room discharges using administrative data. Thromb Res. 2015 Dec;136(6):1195-8. doi: 10.1016/j.thromres.2015.10.035. Epub 2015 Oct 29. | |
26502139 | 0 | Lazo-Langner A. ACP Journal Club. Review: In AF or VTE, direct oral anticoagulants reduce fatal bleeding compared with vitamin K antagonists. Ann Intern Med. 2015 Oct 20;163(8):JC2. doi: 10.7326/ACPJC-2015-163-8-002. | |
26095467 | 0 | Carrier M, Lazo-Langner A, Shivakumar S, et al. Screening for Occult Cancer in Unprovoked Venous Thromboembolism. N Engl J Med. 2015 Aug 20;373(8):697-704. doi: 10.1056/NEJMoa1506623. Epub 2015 Jun 22. | |
25890452 | 0 | Lazo-Langner A, Kovacs MJ, Hedley B, et al. Screening of patients with idiopathic venous thromboembolism for paroxysmal nocturnal hemoglobinuria clones. Thromb Res. 2015 Jun;135(6):1107-9. doi: 10.1016/j.thromres.2015.04.006. Epub 2015 Apr 11. | |
25515959 | 0 | Kang M, Alahmadi M, Sawh S, et al. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study. Blood. 2015 Feb 5;125(6):924-9. doi: 10.1182/blood-2014-09-599498. Epub 2014 Dec 16. |